Investigating the promising SARS-CoV-2 main protease inhibitory activity of secoiridoids isolated from Jasminum humile; in silico and in Vitro assessments with structure-activity relationship.
J Biomol Struct Dyn
; : 1-13, 2023 Jul 28.
Article
in En
| MEDLINE
| ID: mdl-37505066
HIGHLIGHTSSeven isolates from J. humile, besides different extracts, were examined both in vitro and in silico.Anti-SARS-CoV-2 using the MTT assay and anti-SARS-CoV-2 Mpro inhibitory assay were performed.Compounds MJN, JMD, and IJM displayed prominent SARS-CoV-2 Mpro inhibition.Molecular docking, molecular dynamics simulations, and MM-GBSA calculations were carried out.SAR study was conducted on the isolated compounds.
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
J Biomol Struct Dyn
Year:
2023
Type:
Article
Affiliation country:
Egypt